Clinical Trial Update: Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of a combination immunotherapy for advanced renal cell carcinoma is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Michael B. Atkins, MD | Conditions: Advanced Renal Cell Carcinoma | Phase 2 | Status: SUSPENDED